Lab Med Online.  2017 Jul;7(3):94-102. 10.3343/lmo.2017.7.3.94.

Current Status of Standard Diagnostics and Treatment for Malaria, Tuberculosis, and Hepatitis in Myanmar

  • 1Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Korea.
  • 2International Tuberculosis Research Center (ITRC), Changwon, Korea.
  • 3Department of Molecular Biology, College of Natural Science, Pusan National University, Busan, Korea.
  • 4Department of Laboratory Medicine, School of Medicine, Pusan National University, Busan, Korea.
  • 5Department of Medical Research, Yangon, Myanmar.


Malaria, tuberculosis, and hepatitis are common and notorious infectious diseases in Myanmar. Despite intensive efforts to control these diseases, their prevalence remains high. For malaria, which is a vector-borne disease, a remarkable success in the reduction of new cases has been achieved. However, the annual number of tuberculosis cases has increased over the last few decades, and the prevalence of chronic viral hepatitis infection has been high in Myanmar and other nearby countries. Early detection and prompt treatment are crucial to control these diseases. We have devoted our research efforts to understanding the status of these infectious diseases and working towards their eventual elimination for the last four years with the support of the Korea International Cooperation Agency. In the modern era, an infection that develops in one geographical area can spread globally because national borders do not effectively limit disease transmission. Our efforts to understand the status of infectious diseases in Myanmar will benefit not only Myanmar but also neighboring countries such as Korea.


Myanmar; Malaria; Tuberculosis; Hepatitis
Full Text Links
  • LMO
  • Twitter
  • Facebook
Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: